<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35468586</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Long COVID Optimal Health Program (LC-OHP) to Enhance Psychological and Physical Health: Protocol for a Feasibility Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>e36673</StartPage><MedlinePgn>e36673</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e36673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/36673</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID is a collection of symptoms that develop during or following a confirmed or suspected case of COVID-19, which continue for more than 12 weeks. Despite the negative impact of long COVID on people's lives and functioning, there is no validated treatment or even rehabilitation guidance. What has been recommended thus far is the adoption of holistic management approaches. The Optimal Health Program (OHP) is a brief 5-session, plus booster, psychosocial program designed to support mental and physical well-being that has been used effectively for a range of chronic conditions.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study examines the feasibility and acceptability of employing an especially customized version of OHP (long COVID OHP [LC-OHP]) to improve psychological and physical health of people with long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a feasibility randomized controlled trial that will be running from November 2021 to February 2023. Eligible participants aged 18 years or older who are experiencing symptoms of long COVID will be identified through their secondary practitioners with recruitment to be undertaken by the research team. A total of 60 participants will be randomized into a control (usual care) or an intervention (LC-OHP) group. Outcomes will be feasibility and acceptability of the program (primary); and efficacy of the LC-OHP in improving anxiety, depression, fatigue, self-efficacy, and quality of life (secondary). Up to 20 participants will be interviewed at the end of the trial to explore their experience with the program. Quantitative data will be analyzed using SPSS, and differences between groups will be compared using inferential tests where appropriate. Qualitative data will be transcribed and thematically analyzed to identify common emerging themes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This is an ongoing study, which began in November 2021.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Long COVID has a significant impact on an individual's mental and physical functioning. The LC-OHP has a potential to provide people living with long COVID with additional support and to improve self-efficacy. The findings of this study would identify the feasibility of delivering this program to this population and will provide an indication for the program's effectiveness.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ISRCTN Registry ISRCTN38746119; https://www.isrctn.com/ISRCTN38746119.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/36673.</AbstractText><CopyrightInformation>&#xa9;Hiyam Al-Jabr, Karen Windle, David R Thompson, Zoe M Jenkins, David J Castle, Chantal F Ski. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 12.05.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Al-Jabr</LastName><ForeName>Hiyam</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4038-3996</Identifier><AffiliationInfo><Affiliation>Integrated Care Academy, University of Suffolk, Ipswich, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Windle</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2136-735X</Identifier><AffiliationInfo><Affiliation>Integrated Care Academy, University of Suffolk, Ipswich, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Thompson</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0001-8518-6307</Identifier><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jenkins</LastName><ForeName>Zoe M</ForeName><Initials>ZM</Initials><Identifier Source="ORCID">0000-0002-8551-0792</Identifier><AffiliationInfo><Affiliation>Mental Health Service, St Vincent's Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Castle</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-3075-1580</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ski</LastName><ForeName>Chantal F</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0003-1324-2933</Identifier><AffiliationInfo><Affiliation>Integrated Care Academy, University of Suffolk, Ipswich, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">health intervention</Keyword><Keyword MajorTopicYN="N">integrated care</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">optimal health program</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">patient care</Keyword><Keyword MajorTopicYN="N">patient support</Keyword><Keyword MajorTopicYN="N">physical health</Keyword><Keyword MajorTopicYN="N">psychological health</Keyword><Keyword MajorTopicYN="N">telehealth</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword></KeywordList><CoiStatement>Conflicts of Interest: In the past 36 months, DJC has received grant money for research from Servier, Boehringer Ingelheim and Travel Support and Honoraria for Talks and Consultancy from Servier, Seqirus, Lundbeck. He is a founder of the Optimal Health Program (OHP) and holds 50% of the IP for OHP. He is also part owner of Clarity Healthcare. He does not knowingly have stocks or shares in any pharmaceutical company. HAJ, KW, DRT, ZMJ, and CFS declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>25</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35468586</ArticleId><ArticleId IdType="pmc">PMC9106280</ArticleId><ArticleId IdType="doi">10.2196/36673</ArticleId><ArticleId IdType="pii">v11i5e36673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whittaker A, Anson M, Harky A. Neurological Manifestations of COVID-19: A systematic review and current update. Acta Neurol Scand. 2020 Jul 02;142(1):14&#x2013;22. doi: 10.1111/ane.13266. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13266</ArticleId><ArticleId IdType="pmc">PMC7273036</ArticleId><ArticleId IdType="pubmed">32412088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: What do we know about "long covid"? BMJ. 2020 Jul 14;370:m2815. doi: 10.1136/bmj.m2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020 Aug;52:102066. doi: 10.1016/j.ajp.2020.102066. 
 
S1876-2018(20)30177-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2020.102066</ArticleId><ArticleId IdType="pmc">PMC7151415</ArticleId><ArticleId IdType="pubmed">32302935</ArticleId></ArticleIdList></Reference><Reference><Citation>Number of coronavirus (COVID-19) cases, recoveries, and deaths worldwide as of July 5, 2021. Statista.  [2021-07-06].  
 https://www.statista.com/statistics/1087466/covid19-cases-recoveries-deaths-worldwide
.</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. World Health Organization.  [2021-07-06].  
 https://covid19.who.int/
</Citation></Reference><Reference><Citation>Adhikari SP, Meng S, Wu Y, Mao Y, Ye R, Wang Q, Sun C, Sylvia S, Rozelle S, Raat H, Zhou H. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x. 
 
10.1186/s40249-020-00646-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00646-x</ArticleId><ArticleId IdType="doi">10.1186/s40249-020-00646-x</ArticleId><ArticleId IdType="pmc">PMC7079521</ArticleId><ArticleId IdType="pubmed">32183901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Ren Z. Disinfection measures for pneumonia foci infected by novel coronavirus in 2019. Chin J Disinfect. 2020;37:59&#x2013;62. doi: 10.11762/j.issn.1001-7658.2020.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.11762/j.issn.1001-7658.2020.01.019</ArticleId></ArticleIdList></Reference><Reference><Citation>How long does COVID-19 last? Zoe COVID Study. 2020. Jun 06,  [2021-07-01].  
 https://covid.joinzoe.com/post/covid-long-term
.</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72&#x202f;314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 07;323(13):1239&#x2013;1242. doi: 10.1001/jama.2020.2648.2762130</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, World Health Organization  Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) Brazilian Journal of Implantology and Health Sciences. 2020.  [2022-05-02].  
 https://bjihs.emnuvens.com.br/bjihs/article/view/172
.</Citation></Reference><Reference><Citation>Stengel A, Malek N, Zipfel S, Goepel S. Long Haulers-What Is the Evidence for Post-COVID Fatigue? Front Psychiatry. 2021 May 21;12:677934. doi: 10.3389/fpsyt.2021.677934. doi: 10.3389/fpsyt.2021.677934.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.677934</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2021.677934</ArticleId><ArticleId IdType="pmc">PMC8175784</ArticleId><ArticleId IdType="pubmed">34093286</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. The Lancet Respiratory Medicine. 2021 Feb;9(2):129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021 Aug 09;11(1):16144. doi: 10.1038/s41598-021-95565-8. doi: 10.1038/s41598-021-95565-8.10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007. 
 
S1871-4021(21)00119-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020 Sep 07;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021 Oct 02;75(10):e14357. doi: 10.1111/ijcp.14357. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: the NHS plan for 2021/22. National Health Service. 2021. Jun 15,  [2022-05-02].  
 https://www.england.nhs.uk/coronavirus/publication/long-covid-the-nhs-plan-for-2021-22/
</Citation></Reference><Reference><Citation>Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y. 
 
10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, Zhang C, Yue J, Zhang Z, Renz H, Liu X, Xie J, Xie M, Zhao J. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020 Jul;146(1):110&#x2013;118. doi: 10.1016/j.jaci.2020.04.006. 
 
S0091-6749(20)30495-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7152876</ArticleId><ArticleId IdType="pubmed">32294485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021 Mar 03;75(3):e13746. doi: 10.1111/ijcp.13746. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061&#x2013;1069. doi: 10.1001/jama.2020.1585. 
 
2761044</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, Heightman M, Hillman TE, Jacob J, Jarvis HC, Lipman MCI, Naidu SB, Nair A, Porter JC, Tomlinson GS, Hurst JR, Study Group Arc. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021 Apr 10;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818. 
 
thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT, Hyams C, Bibby A, Moran E, Adamali HI, Dodd JW, Maskell NA, Barratt SL. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021 Apr 03;76(4):399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086. 
 
thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR, Network Investigators IVY, CDC COVID-19 Response Team. Network Investigators IVY. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993&#x2013;998. doi: 10.15585/mmwr.mm6930e1. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus (COVID-19) latest insights. Office for National Statistics. 2021.  [2021-07-13].  
 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights
.</Citation></Reference><Reference><Citation>New research shows 2 million people may have had long COVID. Department of Health and Social Care. 2021.  [2022-05-02].  
 https://www.gov.uk/government/news/new-research-shows-2-million-people-may-have-had-long-covid
.</Citation></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021 Jan 22;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O'Brien K, Sheill G, Dyer A, O'Kelly B, Hynes JP, Mooney A, Dunne J, Ni Cheallaigh C, O'Farrelly C, Bourke NM, Conlon N, Martin-Loeches I, Bergin C, Nadarajan P, Bannan C. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc. 2021 Jun;18(6):997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerwyn M, Maes M. Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings. Curr Rheumatol Rep. 2017 Jan 23;19(1):1. doi: 10.1007/s11926-017-0628-x.10.1007/s11926-017-0628-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0628-x</ArticleId><ArticleId IdType="pubmed">28116577</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Facing up to long COVID. The Lancet. 2020 Dec;396(10266):1861. doi: 10.1016/s0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020 Aug 11;324(6):603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O'Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020 Dec;4(5) doi: 10.3399/bjgpopen20X101143. 
 
bjgpopen20X101143</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris) 2021 Jan;177(1-2):51&#x2013;64. doi: 10.1016/j.neurol.2020.10.001. 
 
S0035-3787(20)30732-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 Jul;7(7):611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0. 
 
S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F, Rovere-Querini P, COVID-19 BioB Outpatient Clinic Study group. Benedetti F. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020 Oct;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037. 
 
S0889-1591(20)31606-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerging evidence on COVID-19?s impact on mental health and health inequalities. The Health Foundation. 2020.  [2022-05-02].  
 https://www.health.org.uk/news-and-comment/blogs/emerging-evidence-on-covid-19s-impact-on-mental-health-and-health
.</Citation></Reference><Reference><Citation>Moss R. Long Covid: These Are The Symptoms And Treatments. Huffington Post. 2021. Jun 24,  [2022-05-02].  
 https://www.huffingtonpost.co.uk/entry/long-covid-symptoms-treatments_uk_60d446cde4b052e474fe59e8
.</Citation></Reference><Reference><Citation>Sissons B. What to know about long COVID. Medical News Today. 2021.  [2022-05-02].  
 https://www.medicalnewstoday.com/articles/long-covid
.</Citation></Reference><Reference><Citation>Sampson V. Long Covid: A Complex Health Crisis That Needs Individualised, Integrated &amp; Holistic Support. Craniosacral. 2021.  [2022-05-02].  
 https://www.craniosacral.co.uk/blog/long-covid/
</Citation></Reference><Reference><Citation>Realising the True Value of Integrated Care: Beyond COVID-19. International Foundation for Integrated Care. 2020.  [2022-05-02].  
 https://integratedcarefoundation.org/publications/realising-the-true-value-of-integrated-care-beyond-covid-19-2
.</Citation></Reference><Reference><Citation>Supporting your recovery after COVID-19. National Health Service. 2020.  [2021-07-07].  
 https://www.yourcovidrecovery.nhs.uk/
</Citation></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long term effects of COVID-19. National Institute for Health and Care Excellence. 2020. Dec 18,  [2022-05-02].  
 http://www.nice.org.uk/guidance/ng188
.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawton K, Casey D, Bale E, Brand F, Ness J, Waters K, Kelly S, Geulayov G. Self-harm during the early period of the COVID-19 pandemic in England: Comparative trend analysis of hospital presentations. J Affect Disord. 2021 Mar 01;282:991&#x2013;995. doi: 10.1016/j.jad.2021.01.015. 
 
S0165-0327(21)00028-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.01.015</ArticleId><ArticleId IdType="pmc">PMC7832687</ArticleId><ArticleId IdType="pubmed">33601744</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Jones P, Underwood B, Moore A, Bullmore E, Banerjee S, Osimo EF, Deakin JB, Hatfield CF, Thompson FJ, Artingstall JD, Slann MP, Lewis JR, Cardinal RN. The early impact of COVID-19 on mental health and community physical health services and their patients' mortality in Cambridgeshire and Peterborough, UK. J Psychiatr Res. 2020 Dec;131:244&#x2013;254. doi: 10.1016/j.jpsychires.2020.09.020. 
 
S0022-3956(20)30984-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7508053</ArticleId><ArticleId IdType="pubmed">33035957</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan Rains L, Johnson S, Barnett P, Steare T, Needle J, Carr S, Lever Taylor B, Bentivegna F, Edbrooke-Childs J, Scott HR, Rees J, Shah P, Lomani J, Chipp B, Barber N, Dedat Z, Oram S, Morant N, Simpson A, COVID-19 Mental Health Policy Research Unit Group  Early impacts of the COVID-19 pandemic on mental health care and on people with mental health conditions: framework synthesis of international experiences and responses. Soc Psychiatry Psychiatr Epidemiol. 2021 Jan;56(1):13&#x2013;24. doi: 10.1007/s00127-020-01924-7. 
 
10.1007/s00127-020-01924-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00127-020-01924-7</ArticleId><ArticleId IdType="pmc">PMC7429938</ArticleId><ArticleId IdType="pubmed">32804258</ArticleId></ArticleIdList></Reference><Reference><Citation>Mental health services monthly statistics. National Health Service. 2021.  [2021-09-28].  
 https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/mental-health-data-hub/mental-health-services-monthly-statistics
.</Citation></Reference><Reference><Citation>Mental Health Watch. Royal College of Psychiatrists. 2021.  [2021-09-28].  
 https://mentalhealthwatch.rcpsych.ac.uk/
</Citation></Reference><Reference><Citation>Mental Health Services Monthly Statistics Final March, Provisional April 2021. National Health Service.  [2021-09-28].  
 https://digital.nhs.uk/data-and-information/publications/statistical/mental-health-services-monthly-statistics/final-march-2021
.</Citation></Reference><Reference><Citation>Personal and economic well-being in Great Britain. Office for National Statistics. 2020.  [2021-09-29].  
 https://www.ons.gov.uk/peoplepopulationandcommunity/wellbeing/bulletins/personalandeconomicwellbeingintheuk/may2020
.</Citation></Reference><Reference><Citation>Analysis of RCPsych member survey - beds and out of area placements. Royal College of Psychiatrists. 2021.  [2021-09-28].  
 https://www.rcpsych.ac.uk/docs/default-source/about-us/covid-19/policy---beds-survey---january-2021.pdf?sfvrsn=a71970ab_4
.</Citation></Reference><Reference><Citation>O'Shea N. Covid-19 and the nation's mental health. Centre for Mental Health. 2021.  [2021-09-28].  
 https://www.centreformentalhealth.org.uk/sites/default/files/publication/download/CentreforMentalHealth_COVID_MH_Forecasting4_May21.pdf
.</Citation></Reference><Reference><Citation>Young K, Purves K, H&#xfc;bel C, Davies M, Thompson K, Bristow S. Depression, anxiety and PTSD symptoms before and during the COVID-19 pandemic in the UK. PsyArXiv Preprints. 2021 May 14;:6. doi: 10.31234/osf.io/sf7b6.</Citation><ArticleIdList><ArticleId IdType="doi">10.31234/osf.io/sf7b6</ArticleId></ArticleIdList></Reference><Reference><Citation>Mental health impacts of the COVID 19 pandemic on adults. UK Parliament. 2021.  [2021-09-28].  
 https://post.parliament.uk/research-briefings/post-pn-0648/
</Citation></Reference><Reference><Citation>Gilbert MM, Chamberlain JA, White CR, Mayers PW, Pawsey B, Liew D, Musgrave M, Crawford K, Castle DJ. Controlled clinical trial of a self-management program for people with mental illness in an adult mental health service - the Optimal Health Program (OHP) Aust. Health Review. 2012;36(1):1. doi: 10.1071/ah11008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1071/ah11008</ArticleId><ArticleId IdType="pubmed">22513012</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Education and Counseling. 2002 Oct;48(2):177&#x2013;187. doi: 10.1016/S0738-3991(02)00032-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0738-3991(02)00032-0</ArticleId><ArticleId IdType="pubmed">12401421</ArticleId></ArticleIdList></Reference><Reference><Citation>Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. The Lancet. 2007 Mar;369(9565):946&#x2013;955. doi: 10.1016/s0140-6736(07)60159-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(07)60159-7</ArticleId><ArticleId IdType="pubmed">17368156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrier L, Ski CF, O'Brien C, Jenkins Z, Thompson DR, Moore G, Ward G, Castle DJ. Bridging the gap between diabetes care and mental health: perspectives of the Mental health IN DiabeteS Optimal Health Program (MINDS OHP) BMC Endocr Disord. 2021 May 08;21(1):96. doi: 10.1186/s12902-021-00760-3. 
 
10.1186/s12902-021-00760-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-021-00760-3</ArticleId><ArticleId IdType="doi">10.1186/s12902-021-00760-3</ArticleId><ArticleId IdType="pmc">PMC8105945</ArticleId><ArticleId IdType="pubmed">33964904</ArticleId></ArticleIdList></Reference><Reference><Citation>Minshall C, Castle DJ, Thompson DR, Pascoe M, Cameron J, McCabe M, Apputhurai P, Knowles SR, Jenkins Z, Ski CF. A psychosocial intervention for stroke survivors and carers: 12-month outcomes of a randomized controlled trial. Top Stroke Rehabil. 2020 Dec 19;27(8):563&#x2013;576. doi: 10.1080/10749357.2020.1738677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10749357.2020.1738677</ArticleId><ArticleId IdType="pubmed">32191569</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins ZM, Tan EJ, O'Flaherty E, Knowles S, Thompson DR, Ski CF, Rossell SL, Coco C, Ierino FL, Gock H, Castle DJ. A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trial. Nephrology (Carlton) 2021 May 02;26(5):442&#x2013;453. doi: 10.1111/nep.13850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.13850</ArticleId><ArticleId IdType="pubmed">33484221</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  NICE COVID-19 rapid guidelines. PharmacoEcon Outcomes News. 2021;877(1):33. doi: 10.1007/s40274-021-7682-3. 
 
7682</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40274-021-7682-3</ArticleId><ArticleId IdType="pmc">PMC8085796</ArticleId><ArticleId IdType="pubmed">33948079</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan A, Tetzlaff JM, G&#xf8;tzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hr&#xf3;bjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013 Jan 08;346(jan08 15):e7586&#x2013;e7586. doi: 10.1136/bmj.e7586. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e7586</ArticleId><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Billingham SAM, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol. 2013 Aug 20;13:104. doi: 10.1186/1471-2288-13-104. 
 
1471-2288-13-104</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-104</ArticleId><ArticleId IdType="doi">10.1186/1471-2288-13-104</ArticleId><ArticleId IdType="pmc">PMC3765378</ArticleId><ArticleId IdType="pubmed">23961782</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995 Sep 15;14(17):1933&#x2013;40. doi: 10.1002/sim.4780141709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780141709</ArticleId><ArticleId IdType="pubmed">8532986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster G, Dodd S, Williamson P. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307&#x2013;12. doi: 10.1111/j..2002.384.doc.x.JEP384</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j..2002.384.doc.x</ArticleId><ArticleId IdType="pubmed">15189396</ArticleId></ArticleIdList></Reference><Reference><Citation>Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014 Jul 03;15(1):264. doi: 10.1186/1745-6215-15-264. 
 
1745-6215-15-264</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-15-264</ArticleId><ArticleId IdType="doi">10.1186/1745-6215-15-264</ArticleId><ArticleId IdType="pmc">PMC4227298</ArticleId><ArticleId IdType="pubmed">24993581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606&#x2013;13. doi: 10.1046/j.1525-1497.2001.016009606.x. 
 
jgi01114</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinson RP. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid Based Med. 2006 Dec 01;11(6):184&#x2013;184. doi: 10.1136/ebm.11.6.184.11/6/184</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebm.11.6.184</ArticleId><ArticleId IdType="pubmed">17213178</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092&#x2013;7. doi: 10.1001/archinte.166.10.1092.166/10/1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzer R, Jerusalem M. The General Self-Efficacy Scale. APA PsycNet Direct. 1995.  [2022-05-02].  
 https://doi.apa.org/doiLanding?doi=10.1037%2Ft00393-000
.</Citation></Reference><Reference><Citation>Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013 Sep 25;22(7):1717&#x2013;27. doi: 10.1007/s11136-012-0322-4. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-012-0322-4</ArticleId><ArticleId IdType="pmc">PMC3764313</ArticleId><ArticleId IdType="pubmed">23184421</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011 Dec;20(10):1727&#x2013;36. doi: 10.1007/s11136-011-9903-x. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kleijn WP, De Vries J, Wijnen PA, Drent M. Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. Respir Med. 2011 Sep;105(9):1388&#x2013;95. doi: 10.1016/j.rmed.2011.05.004. 
 
S0954-6111(11)00167-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2011.05.004</ArticleId><ArticleId IdType="pubmed">21700440</ArticleId></ArticleIdList></Reference><Reference><Citation>Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J. 2012 Jul 22;40(1):255&#x2013;63. doi: 10.1183/09031936.00002512. 
 
09031936.00002512</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00002512</ArticleId><ArticleId IdType="pubmed">22441750</ArticleId></ArticleIdList></Reference><Reference><Citation>Castle DJ, Gilbert M. Collaborative therapy: framework for mental health. Br J Psychiatry. 2006 Nov 02;189(5):467&#x2013;467. doi: 10.1192/bjp.189.5.467.S0007125000232996</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.189.5.467</ArticleId><ArticleId IdType="pubmed">17077443</ArticleId></ArticleIdList></Reference><Reference><Citation>Castle D, White C, Chamberlain J, Berk M, Berk L, Lauder S, Murray G, Schweitzer I, Piterman L, Gilbert M. Group-based psychosocial intervention for bipolar disorder: randomised controlled trial. Br J Psychiatry. 2010 May 02;196(5):383&#x2013;8. doi: 10.1192/bjp.bp.108.058263.S0007125000252525</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.108.058263</ArticleId><ArticleId IdType="pubmed">20435965</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien CL, Moore G, Rolley JX, Ski CF, Thompson DR, Lautenschlager NT, Gonzales G, Hsueh Y, Castle D. Exploring health care providers' perceptions of the needs of stroke carers: informing development of an optimal health program. Top Stroke Rehabil. 2014 Dec 22;21(5):421&#x2013;31. doi: 10.1310/tsr2105-421.U514188K4V28P563</Citation><ArticleIdList><ArticleId IdType="doi">10.1310/tsr2105-421</ArticleId><ArticleId IdType="pubmed">25341387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ski CF, Castle DJ, Lautenschlager NT, Moore G, Thompson DR. Caring for caregivers after a stroke. Int. Psychogeriatr. 2014 Nov 10;27(1):1&#x2013;4. doi: 10.1017/s1041610214002385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610214002385</ArticleId><ArticleId IdType="pubmed">25381810</ArticleId></ArticleIdList></Reference><Reference><Citation>Brereton L, Carroll C, Barnston S. Interventions for adult family carers of people who have had a stroke: a systematic review. Clin Rehabil. 2007 Oct 01;21(10):867&#x2013;84. doi: 10.1177/0269215507078313.21/10/867</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269215507078313</ArticleId><ArticleId IdType="pubmed">17981846</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldred C, Sykes C. Psychosocial interventions for carers of survivors of stroke: a systematic review of interventions based on psychological principles and theoretical frameworks. Br J Health Psychol. 2008 Sep;13(Pt 3):563&#x2013;81. doi: 10.1348/135910707X236899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/135910707X236899</ArticleId><ArticleId IdType="pubmed">17708832</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006 Jan;3(2):77&#x2013;101. doi: 10.1191/1478088706qp063oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>